We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Slaps Validus With Untitled Letter for False Website Claims on Equetro
FDA Slaps Validus With Untitled Letter for False Website Claims on Equetro
October 3, 2012
The FDA issued an untitled letter to Validus Pharmaceuticals claiming the drugmaker’s website published misleading claims for its bipolar disorder drug Equetro.